Cargando…
_version_ 1785090727846346752
author Krüger, Katja
Wichmann, Martin
Gabdoulline, Razif
Götze, Katharina
Braitsch, Krischan
Modemann, Franziska
Fiedler, Walter
Trummer, Arne
Krauter, Jürgen
Kaun, Stephan
Rotermund, Susanne
Voß, Andreas
Goehring, Gudrun
Behrens, Yvonne
Thol, Felicitas
Eder, Matthias
Beutel, Gernot
Stadler, Michael
Heuser, Michael
Shahswar, Rabia
author_facet Krüger, Katja
Wichmann, Martin
Gabdoulline, Razif
Götze, Katharina
Braitsch, Krischan
Modemann, Franziska
Fiedler, Walter
Trummer, Arne
Krauter, Jürgen
Kaun, Stephan
Rotermund, Susanne
Voß, Andreas
Goehring, Gudrun
Behrens, Yvonne
Thol, Felicitas
Eder, Matthias
Beutel, Gernot
Stadler, Michael
Heuser, Michael
Shahswar, Rabia
author_sort Krüger, Katja
collection PubMed
description
format Online
Article
Text
id pubmed-10429491
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104294912023-08-17 P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY Krüger, Katja Wichmann, Martin Gabdoulline, Razif Götze, Katharina Braitsch, Krischan Modemann, Franziska Fiedler, Walter Trummer, Arne Krauter, Jürgen Kaun, Stephan Rotermund, Susanne Voß, Andreas Goehring, Gudrun Behrens, Yvonne Thol, Felicitas Eder, Matthias Beutel, Gernot Stadler, Michael Heuser, Michael Shahswar, Rabia Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429491/ http://dx.doi.org/10.1097/01.HS9.0000968948.19815.ef Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Krüger, Katja
Wichmann, Martin
Gabdoulline, Razif
Götze, Katharina
Braitsch, Krischan
Modemann, Franziska
Fiedler, Walter
Trummer, Arne
Krauter, Jürgen
Kaun, Stephan
Rotermund, Susanne
Voß, Andreas
Goehring, Gudrun
Behrens, Yvonne
Thol, Felicitas
Eder, Matthias
Beutel, Gernot
Stadler, Michael
Heuser, Michael
Shahswar, Rabia
P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
title P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
title_full P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
title_fullStr P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
title_full_unstemmed P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
title_short P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
title_sort p510: predictors of response and outcome in patients with refractory/relapsed acute myeloid leukemia receiving venetoclax with non-intensive chemotherapy
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429491/
http://dx.doi.org/10.1097/01.HS9.0000968948.19815.ef
work_keys_str_mv AT krugerkatja p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT wichmannmartin p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT gabdoullinerazif p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT gotzekatharina p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT braitschkrischan p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT modemannfranziska p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT fiedlerwalter p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT trummerarne p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT krauterjurgen p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT kaunstephan p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT rotermundsusanne p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT voßandreas p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT goehringgudrun p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT behrensyvonne p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT tholfelicitas p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT edermatthias p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT beutelgernot p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT stadlermichael p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT heusermichael p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy
AT shahswarrabia p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy